Background & Objectives: Parkinson's disease (PD) is the most prevalent neurodegenerative disorder, beginning in the in the substantia nigra and spreading to the subcortical structures to the limbic cortices, and eventually to the neocortex and is characterized clinically by tremor at rest, bradykinesia, and rigidity. Regional brain atrophy is found to be an important marker of PD's pathology. The aim of the current study was to compare the volumes of subcortical brain structures between healthy subjects and patients with PD using stereological (point-counting) and semi-automated segmentation methods
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Parkinson disease (PD) is characterized by motor deficits related to structural changes in the basal...
Objective: To test the hypothesis that degeneration of the substantia nigra pars compacta (SNc) prec...
Background & Objectives: Parkinson's disease (PD) is the most prevalent neurodegenerative disorder, ...
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associ...
Magnetic resonance imaging (MRI) is an imaging modality that uses magnetic fields, field gradients a...
BACKGROUND AND PURPOSE: Parkinson's disease (PD) is a progressive neurodegenerative disorder with mo...
Parkinson's disease (PD) is associated with degeneration of the dopaminergic neurons in the substant...
Background and purpose Parkinson's disease (PD) patients with cognitive impairment undergo progressi...
Parkinson's disease (PD) is a progressive neurological disorder that has no reliable biomarkers. The...
Previous imaging studies that investigated morphometric group differences of subcortical regions out...
Parkinson's disease (PD), characterized by motor dysfunction and cognitive decline, may demonstrate ...
The primary aim of this work is to investigate the value of quantitative magnetic resonance imaging ...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
One objective of modern neuroimaging is to identify markers that can aid in diagnosis, disease progr...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Parkinson disease (PD) is characterized by motor deficits related to structural changes in the basal...
Objective: To test the hypothesis that degeneration of the substantia nigra pars compacta (SNc) prec...
Background & Objectives: Parkinson's disease (PD) is the most prevalent neurodegenerative disorder, ...
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associ...
Magnetic resonance imaging (MRI) is an imaging modality that uses magnetic fields, field gradients a...
BACKGROUND AND PURPOSE: Parkinson's disease (PD) is a progressive neurodegenerative disorder with mo...
Parkinson's disease (PD) is associated with degeneration of the dopaminergic neurons in the substant...
Background and purpose Parkinson's disease (PD) patients with cognitive impairment undergo progressi...
Parkinson's disease (PD) is a progressive neurological disorder that has no reliable biomarkers. The...
Previous imaging studies that investigated morphometric group differences of subcortical regions out...
Parkinson's disease (PD), characterized by motor dysfunction and cognitive decline, may demonstrate ...
The primary aim of this work is to investigate the value of quantitative magnetic resonance imaging ...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
One objective of modern neuroimaging is to identify markers that can aid in diagnosis, disease progr...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Parkinson disease (PD) is characterized by motor deficits related to structural changes in the basal...
Objective: To test the hypothesis that degeneration of the substantia nigra pars compacta (SNc) prec...